The French software company said the Committee on Foreign
Investment in the United States is required to complete its
investigation of the acquisition until May 8 but could complete it
earlier than that.
"Dassault Systemes continues to believe the acquisition of
Accelrys by Dassault Systemes does not raise national security
concerns," the company said in a statement.
The tender offer is extended only until April 22 because of an
agreement with Accelrys that the offer can only be extended in 10
business day blocks.
Dassault Systemes offered in late January to pay $12.50 for each
Accelrys share, valuing the company at $750 million. Accelrys
shares were traded at $9.72 before the offer.
Dassault Systemes said except for the extension, all other terms
of the offer remain unchanged.
San Diego-based Accelrys makes biotech, petrochemical and
pharmaceutical industrial software for companies like Sanofi,
Pfizer, Royal Dutch Shell, Unilever and L'Oreal.
Write to Ruth Bender at ruth.bender@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires